Changes in the structure and function of normal cellular genes lie at the heart of carcinogenesis. The work supported by this grant seeks to identify cellular genes responsible for cancerous growth, the means by which carcinogens bring these genes into play, and the biochemical mechanisms by which the genes act. If the search succeeds, it should provide new and more rational strategies for the prevention, diagnosis and therapy of cancer; and it should also reveal principles by which the normal growth and development of cells are controlled. The work is conducted primarily with retroviruses, whose tumorigenic potentials represent a microcosm of carcinogenesis. Some of these viruses carry """"""""oncogenes"""""""" that directly convert cells to neoplastic growth. Other retroviruses do not possess oncogenes but instead induce tumors by mutating the DNA of host cells. Both forms of tumorigenesis by retroviruses offer access to cellular genes that may contribute to neoplastic growth: the oncogene of retroviruses are partial of complete copies of normal cellular genes (""""""""proto-oncogenes""""""""), transduced into the viruses by accident during the course of evaluation; and the mutagenesis of cellular DNA by retroviruses activates genes that can also be regarded as proto-oncogenes. A suite of avian retroviruses is used that, in the aggregate, provides experimental models for most of the major forms of cancer. Among these viruses are represented five oncogenes (v-src, v-fps, v-myc, v-erb-B, and v-myb) that are major objects of study. Experimental strategies are aimed at identifying the proteins encoded by oncogenes and proto- oncogenes; determining the functions of these proteins in their normal guise; discerning changes in their function that may account for tumorigenesis; identifying cellular functions whose perversion by oncogenes are involved in the genesis of human tumors; and exploiting the discovery of proto-oncogenes to perform genetic and biochemical analyses of how the growth and differentiation of normal cells is controlled. Methods include molecular cloning; nucleotide sequencing; DNA-mediated gene transfer; preparation of both polyclonal and monoclonal antibodies; immunoprecipitation; immunofluorescence and electron microscopy; purification and chemical analysis of proteins; site-directed mutagenesis with recombinant DNA; and genetic analyses with both Drosophila melanogaster and Saccharomyces cerevisiae.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
5R35CA044338-06
Application #
3479496
Study Section
Special Emphasis Panel (SRC (88))
Project Start
1987-07-01
Project End
1994-06-30
Budget Start
1992-07-01
Budget End
1993-06-30
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Yuneva, Mariia O; Fan, Teresa W M; Allen, Thaddeus D et al. (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab 15:157-70
Qu, Jian; Bishop, J Michael (2012) Nucleostemin maintains self-renewal of embryonic stem cells and promotes reprogramming of somatic cells to pluripotency. J Cell Biol 197:731-45
Kim, Suwon; Welm, Alana L; Bishop, J Michael (2010) A dominant mutant allele of the ING4 tumor suppressor found in human cancer cells exacerbates MYC-initiated mouse mammary tumorigenesis. Cancer Res 70:5155-62
Field, Kenneth A; Charoenthongtrakul, Soratree; Bishop, J Michael et al. (2008) Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas. Mol Cancer 7:39
He, Chen; Hu, Huiqing; Braren, Rickmer et al. (2008) c-myc in the hematopoietic lineage is crucial for its angiogenic function in the mouse embryo. Development 135:2467-77
Welm, Alana L; Sneddon, Julie B; Taylor, Carmen et al. (2007) The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci U S A 104:7570-5
Braren, Rickmer; Hu, Huiqing; Kim, Yung Hae et al. (2006) Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation. J Cell Biol 172:151-62
Carpenter, Brian; Lin, Yuankai; Stoll, Stephanie et al. (2005) VEGF is crucial for the hepatic vascular development required for lipoprotein uptake. Development 132:3293-303
Kim, Suwon; Chin, Koei; Gray, Joe W et al. (2004) A screen for genes that suppress loss of contact inhibition: identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci U S A 101:16251-6
Yang, Dun; Goga, Andrei; Bishop, J Michael (2004) RNA interference (RNAi) with RNase III-prepared siRNAs. Methods Mol Biol 252:471-82

Showing the most recent 10 out of 78 publications